UB Paderborn / Katalog / Suche / in CDI

Immediate Versus Deferred Hormonal Treatment for Patients With Prostate Cancer Who Are Not Suitable for Curative Local Treatment: Results of the Randomized Trial SAKK 08/88

Journal of clinical oncology, 2004-10, Vol.22 (20), p.4109-4118

2004

Volltextzugriff (PDF)

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

The Lancet (British edition), 2014-12, Vol.384 (9959), p.2027-2035

2014

Volltextzugriff (PDF)

In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic “gray zone” of total PSA 4 to 10 ng/mL

Urology (Ridgewood, N.J.), 1998-09, Vol.52 (3), p.360-365

1998

Volltextzugriff (PDF)

Prostate-Cancer Mortality at 11 Years of Follow-up

The New England journal of medicine, 2012-03, Vol.366 (11), p.981-990

2012

Volltextzugriff (PDF)

Screening and Prostate-Cancer Mortality in a Randomized European Study

The New England journal of medicine, 2009-03, Vol.360 (13), p.1320-1328

2009

Volltextzugriff (PDF)

PROSPECTIVE DETECTION OF CLINICALLY RELEVANT PROSTATE CANCER IN THE PROSTATE SPECIFIC ANTIGEN RANGE 1 TO 3 NG./ML. COMBINED WITH FREE-TO-TOTAL RATIO 20% OR LESS: THE AARAU EXPERIENCE

The Journal of urology, 2001-09, Vol.166 (3), p.851-855

2001

Volltextzugriff (PDF)

Human glandular kallikrein as a tool to improve discrimination of poorly differentiated and non-organ-confined prostate cancer compared with prostate-specific antigen

Urology (Ridgewood, N.J.), 2000-04, Vol.55 (4), p.481-485

2000

Volltextzugriff (PDF)

VARIOUS RATIOS OF HUMAN GLANDULAR KALLIKREIN (HK2) TO FREE AND TOTAL PSA IMPROVE DISCRIMINATION BETWEEN G1-G2 AND G3 PROSTATE TUMORS

The Journal of urology, 1999-04, p.239

1999

Volltextzugriff (PDF)

The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma

Cancer, 1998-12, Vol.83 (12), p.2540-2547

1998

Volltextzugriff (PDF)

Incidence of Erectile Impotence Secondary to Transurethral Resection of Benign Prostatic Hyperplasia, Assessed by Preoperative and Postoperative Snap Gauge Tests

The Journal of urology, 1995-05, Vol.153 (5), p.1491-1493

1995

Volltextzugriff (PDF)

Medizinalisierung der Drogen aus Sicht eines Mediziners

SuchtMagazin, 1998-10, Vol.24 (5), p.30

Tscholl, Reto

1998

Volltextzugriff (PDF)

PROSPECTIVE DETECTION OF CLINICALLY RELEVANT PROSTATE CANCER IN THE PROSTATE SPECIFIC ANTIGEN RANGE 1 TO 3 NG./ML. COMBINED WITH FREE-TO-TOTAL RATIO 20% OR LESS: THE AARAU EXPERIENCE

The Journal of urology, 2001-09, p.851-855

2001

Volltextzugriff (PDF)

Das Musterkind in einem andern Licht

DrogenMagazin : Zeitschrift für Suchtfragen, 1995-02, Vol.21 (1), p.7

Tscholl, Reto

1995

Volltextzugriff (PDF)

FREE, TOTAL PSA AND HUMAN GLANDULAR KALLIKREIN (HK2) IN LONGITUDINAL FOLLOW-UP AFTER TUR-P

The Journal of urology, 1999-04, p.318

1999

Volltextzugriff (PDF)

Enhanced Expression of Prostate-Specific Antigen in the Transition Zone of the Prostate

European urology, 1998-06, Vol.33 (6), p.549-555

1998

Volltextzugriff (PDF)

Incidence of Erectile Impotence Secondary to Transurethral Resection of Benign Prostatic Hyperplasia, Assessed by Preoperative and Postoperative Snap Gauge Tests

The Journal of urology, 1995-05, p.1491-1493

1995

Volltextzugriff (PDF)

Das fibrosierende Angiom des Herzmuskels, zugleich ein Beitrag zur Kenntnis der Hamartome und umschriebenen Schwielen des Myokards

Tscholl, Reto

1967

Volltextzugriff (PDF)

Prospective detection of clinically relevant prostate cancer in the prostate specific antigen range 1 to 3 NG./ ml. combined with free-to-total ratio 20% or less : The Aarau Experience. Commentary

The Journal of urology, 2001, Vol.166 (3), p.851-855

2001

Volltextzugriff (PDF)

Bone autografting in medial open wedge high tibial osteotomy results in improved osseous gap healing on computed tomography, but no functional advantage: a prospective, randomised, controlled trial

Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2019-09, Vol.27 (9), p.2951-2957

2019

Volltextzugriff (PDF)

3D-printed anatomic models of the knee for evaluation of patellofemoral dysplasia in comparison to standard radiographs and computed tomography

European journal of radiology, 2020-06, Vol.127, p.109011-109011, Article 109011

2020

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Immediate Versus Deferred Hormonal Treatment for Patients With Prostate Cancer Who Are Not Suitable for Curative Local Treatment: Results of the Randomized Trial SAKK 08/88

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic “gray zone” of total PSA 4 to 10 ng/mL

Prostate-Cancer Mortality at 11 Years of Follow-up

Screening and Prostate-Cancer Mortality in a Randomized European Study

PROSPECTIVE DETECTION OF CLINICALLY RELEVANT PROSTATE CANCER IN THE PROSTATE SPECIFIC ANTIGEN RANGE 1 TO 3 NG./ML. COMBINED WITH FREE-TO-TOTAL RATIO 20% OR LESS: THE AARAU EXPERIENCE

Human glandular kallikrein as a tool to improve discrimination of poorly differentiated and non-organ-confined prostate cancer compared with prostate-specific antigen

VARIOUS RATIOS OF HUMAN GLANDULAR KALLIKREIN (HK2) TO FREE AND TOTAL PSA IMPROVE DISCRIMINATION BETWEEN G1-G2 AND G3 PROSTATE TUMORS

The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma

Incidence of Erectile Impotence Secondary to Transurethral Resection of Benign Prostatic Hyperplasia, Assessed by Preoperative and Postoperative Snap Gauge Tests

Medizinalisierung der Drogen aus Sicht eines Mediziners

PROSPECTIVE DETECTION OF CLINICALLY RELEVANT PROSTATE CANCER IN THE PROSTATE SPECIFIC ANTIGEN RANGE 1 TO 3 NG./ML. COMBINED WITH FREE-TO-TOTAL RATIO 20% OR LESS: THE AARAU EXPERIENCE

Das Musterkind in einem andern Licht

FREE, TOTAL PSA AND HUMAN GLANDULAR KALLIKREIN (HK2) IN LONGITUDINAL FOLLOW-UP AFTER TUR-P

Enhanced Expression of Prostate-Specific Antigen in the Transition Zone of the Prostate

Incidence of Erectile Impotence Secondary to Transurethral Resection of Benign Prostatic Hyperplasia, Assessed by Preoperative and Postoperative Snap Gauge Tests

Das fibrosierende Angiom des Herzmuskels, zugleich ein Beitrag zur Kenntnis der Hamartome und umschriebenen Schwielen des Myokards

Prospective detection of clinically relevant prostate cancer in the prostate specific antigen range 1 to 3 NG./ ml. combined with free-to-total ratio 20% or less : The Aarau Experience. Commentary

Bone autografting in medial open wedge high tibial osteotomy results in improved osseous gap healing on computed tomography, but no functional advantage: a prospective, randomised, controlled trial

3D-printed anatomic models of the knee for evaluation of patellofemoral dysplasia in comparison to standard radiographs and computed tomography

Suchergebnisse filtern